| CGGFX | CGGGX | CGGFX / CGGGX | |
| Total Expense Ratio | 0.86 | 0.69 | 125% |
| Annual Report Gross Expense Ratio | 0.86 | 0.74 | 116% |
| Fund Existence | 14 years | 8 years | - |
| Gain YTD | 2.999 | 2.978 | 101% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.23B | 7.23B | 100% |
| Annual Yield % from dividends | 0.98 | 0.88 | 110% |
| Returns for 1 year | 17.50 | 17.40 | 101% |
| Returns for 3 years | 52.31 | 51.86 | 101% |
| Returns for 5 years | 22.56 | 22.12 | 102% |
| Returns for 10 years | 138.23 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FTDZX | 179.09 | 0.76 | +0.43% |
| Franklin Biotechnology Discovery Adv | |||
| BBTSX | 13.82 | 0.01 | +0.07% |
| Bridge Builder Tax Managed Sm/Md Cp | |||
| FNCMX | 299.43 | N/A | N/A |
| Fidelity Nasdaq Composite Index | |||
| TRSZX | 22.25 | -0.13 | -0.58% |
| T. Rowe Price Mid-Cap Index Z | |||
| ABPZX | 12.66 | -0.10 | -0.78% |
| AB Sustainable Thematic Balanced Port Z | |||